OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression
Goki Tsujimoto, Rin Ito, Kei Yoshikawa, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7
Goki Tsujimoto, Rin Ito, Kei Yoshikawa, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7
Showing 7 citing articles:
Expression and function of NF-Y subunits in cancer
Diletta Dolfini, Nerina Gnesutta, Roberto Mantovani
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189082-189082
Open Access | Times Cited: 5
Diletta Dolfini, Nerina Gnesutta, Roberto Mantovani
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189082-189082
Open Access | Times Cited: 5
Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
Dan Chen, Ayinuer Aierken, Hui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Dan Chen, Ayinuer Aierken, Hui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma
Zigang Li, Chengshan You, Jun Huang, et al.
Medical Science Monitor (2023) Vol. 29
Open Access | Times Cited: 4
Zigang Li, Chengshan You, Jun Huang, et al.
Medical Science Monitor (2023) Vol. 29
Open Access | Times Cited: 4
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling
Na Liu, Xiaoren Zhu, Christian Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Na Liu, Xiaoren Zhu, Christian Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma
Fan Feng, Lianhong Pan, Jiaqin Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Fan Feng, Lianhong Pan, Jiaqin Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Digital spatial profiling of segmental outflow regions in trabecular meshwork reveals a role for ADAM15
Jennifer A. Faralli, Mark S. Filla, Yong-Feng Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298802-e0298802
Open Access
Jennifer A. Faralli, Mark S. Filla, Yong-Feng Yang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298802-e0298802
Open Access
Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy
Yi‐Tsung Yang, Chi‐Yuan Yao, Chein‐Jun Kao, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 5, pp. 1751-1764
Closed Access
Yi‐Tsung Yang, Chi‐Yuan Yao, Chein‐Jun Kao, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 5, pp. 1751-1764
Closed Access
